|
| | Strictosidinic acid Basic information |
| Product Name: | Strictosidinic acid | | Synonyms: | Strictosidinic acid;(2S,3R,4S)-3-Ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-4-[[(1S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]methyl]-2H-pyran-5-carboxylic acid;2H-Pyran-5-carboxylic acid, 3-ethenyl-2-(β-D-glucopyranosyloxy)-3,4-dihydro-4-[[(1S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]methyl]-, (2S,3R,4S)- | | CAS: | 150148-81-5 | | MF: | C26H32N2O9 | | MW: | 516.54 | | EINECS: | | | Product Categories: | | | Mol File: | 150148-81-5.mol |  |
| | Strictosidinic acid Chemical Properties |
| Boiling point | 792.8±60.0 °C(Predicted) | | density | 1.50±0.1 g/cm3(Predicted) | | storage temp. | 4°C, stored under nitrogen | | pka | 4.67±0.70(Predicted) |
| | Strictosidinic acid Usage And Synthesis |
| Biological Activity | Strictosidinic acid, an glycosidic indole monoterpene alkaloid isolated from the leaves of Psychotria myriantha, inhibits the precursor enzymes of 5-HT biosynthesis and reduces 5-HT content. It has peripheral analgesic and antipyretic activity in mice. | | in vivo | Strictosidinic acid (20 μg/μl; intra-hippocampal injection) causes a significance of 83.5% reduction in 5-HT levels. Strictosidinic acid (10 mg/kg; ip) causes a 63.4% reduction in 5- HT levels and a 67.4% reduction in DOPAC values in male Wistar rats, weighing 200-250 g. | | target | |
| | Strictosidinic acid Preparation Products And Raw materials |
|
